Final survival follow-up and translational associations using interval indirect immunization with oregovomab (O) and poly ICLC in patients (pts) with recurrent platinum-resistant ovarian cancer (PROC). Meeting Abstract

cited authors

  • Holloway, Robert W.; Temkin, Sarah Madhu; Gordon, Sarah W.; Gupta, Sunil; Nicodemus, Christopher F.; Madiyalakan, Madi; McGuire, William P.

Publication Date

  • May 20, 2021

webpage

published in

category

volume

  • 39

issue

  • 15